If you're looking for a Ginkgo Bioworks alternative, Genesis Therapeutics is a good candidate. Its GEMS platform uses AI to speed up the discovery of new drugs by finding new protein targets and previously unexplored chemical compounds. It combines deep learning and molecular simulations to predict properties and generate molecules, making it easier for researchers and developers to design high-potency and selective small molecule drugs.
Another good choice is BenchSci, which offers ASCEND, an AI-powered information retrieval system designed to speed up drug discovery and other complex research workflows. ASCEND offers a large data foundation, enterprise-grade software that can handle large-scale data and biology-specific multimodal AI to interpret experiments. The platform is geared for pharmaceutical and biotech companies that want to accelerate life-saving research.
For more general-purpose bioinformatics, check out QIAGEN Digital Insights. The platform offers expert-curated solutions for genomic and clinical research, including tools like Ingenuity Pathway Analysis and Genomics Workbench Premium. It can be used for variant annotation, filtering and triage, and is used in a variety of applications including biomarker and target discovery, so it's a good option for digging useful information out of big data.